Latest Licensing Agreements News

Page 3 of 23
Audeara has reached a key milestone as its chip-level AI licensing partnership with Optek enters commercial production, receiving initial purchase orders worth about A$31,000. This validates Audeara’s scalable fee-per-chip licensing model and sets the stage for broader applications in audio and hearing health.
Sophie Babbage
Sophie Babbage
4 Aug 2026
Dimerix Limited (ASX: DXB) has inked its fifth regional licensing agreement with Everest Medicines, boosting potential milestone payments to A$1.9 billion and expanded its kidney disease pipeline through the acquisition of DMX-652. The Phase 3 ACTION3 trial for DMX-200 remains statistically robust, with funding secured to advance both clinical programs.
Ada Torres
Ada Torres
30 July 2026
Audeara Ltd posted record FY26 cash receipts of $4.2 million and unaudited revenue of $4.44 million, driven by progress in AI audio licensing, exclusive assistive listening deals, and a large-scale Auracast deployment across retirement villages.
Victor Sage
Victor Sage
30 July 2026
Argent BioPharma has eliminated US$5.5 million in secured debt through a global licensing agreement for its CannEpil® epilepsy therapy, while completing a key acquisition and advancing clinical trials in veterinary therapeutics.
Ada Torres
Ada Torres
28 July 2026
Echo IQ has locked in a strategic $20 million investment and US partnership with Pro Medicus, alongside a $110 million capital raise, positioning the company for accelerated commercial expansion of its AI-driven cardiovascular diagnostics in the US.
Ada Torres
Ada Torres
27 July 2026
FINEOS Corporation Holdings PLC reported a solid €39 million cash balance for Q2 2026 despite a 23% drop in client receipts due to timing. The company locked in a significant 10-year deal with OneAmerica Financial and maintained its FY26 revenue guidance between €147m and €152m.
Sophie Babbage
Sophie Babbage
23 July 2026
Recce Pharmaceuticals secured a non-binding term sheet with a major Middle Eastern pharma for its diabetic foot infection treatment and raised A$4 million to fund pivotal Phase 3 trials in Australia and Indonesia.
Ada Torres
Ada Torres
21 July 2026
Temas Resources has filed a new patent for extracting chromium using its Regenerative Chloride Leach technology, broadening its critical minerals platform and commercial prospects.
Maxwell Dee
Maxwell Dee
13 July 2026
FirstWave Cloud Technology has secured a 12-month extension of its ISM-compliant CyberCision platform agreement with Telstra, increasing annual recurring revenue from Federal Government agencies by 5% to approximately A$0.6 million.
Sophie Babbage
Sophie Babbage
8 July 2026
First Graphene has signed an MOU with Sixth Element to distribute its PureGRAPH® CEM additive across China, with potential for local manufacturing via a joint venture once sales milestones are met.
Maxwell Dee
Maxwell Dee
6 July 2026
Starpharma has reached a key milestone in its collaboration with Radiopharm Theranostics, unlocking a $0.5 million option fee and advancing the partnership toward a potential $91 million licensing deal.
Ada Torres
Ada Torres
3 July 2026
Echo IQ has locked in a pivotal exclusive data licensing deal with Advara HeartCare, gaining access to as many as one million de-identified echocardiography studies, a move set to turbocharge its cardiovascular AI development.
Ada Torres
Ada Torres
2 July 2026

Browse the archive

Full archive